Navigation Links
Align Technology to Announce First Quarter Fiscal 2009 Results on April 23, 2009
Date:4/2/2009

SANTA CLARA, Calif. April 2 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), announced today that the Company will report first quarter 2009 financial results on Thursday, April 23, 2009 after the close of market. Financial results will be released over PR Newswire and First Call and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.

Following the press release, the Company will host a conference call to discuss its financial results. The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio web cast live via the Internet. To access the web cast, please visit the Investor Relations section of Align Technology's website at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call.

If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 318996 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on May 06, 2009.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects maloc
'/>"/>

SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System
2. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
3. Dr. James F. Pingpank to Present at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13- 14, 2009 in New York City
4. A new measure for the malignancy of melanoma
5. Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
6. Precyse Solutions Adds Executives, Realigns Around Service Lines
7. Align Technology Announces International Availability of Invisalign Teen(TM)
8. EMSI Realigns Internal Divisions for More Effective Focus on Customers
9. Video: The MDS Foundation Says Published Data Confirms VIDAZA(R) Significantly Extends Survival in Patients with the Malignant Condition MDS
10. Align Technology Asserts ClearCorrect Complaint Is Without Merit
11. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... The report “Poxvirus Infections Pipeline ... therapeutic development for Poxvirus Infections, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Poxvirus Infections and special features on late-stage ...
(Date:11/28/2014)... November 29, 2014 Recently, PrettyTailor.com has ... dresses for its customers around the world in celebration ... customers, PrettyTailor.com has also launched a special offer on ... more. , As a pioneer in the garment industry, ... products for clients large and small. The business carries ...
(Date:11/28/2014)... The holiday season is fast approaching. As a ... collection of fashionable party dresses. What’s more, the company is ... brand new outfits; the special offer is valid until Dec. ... supplier and it has received a lot of requests for ... designed to flatter various body shapes; they are available in ...
(Date:11/28/2014)... 28, 2014 Now that the holiday ... one of the nation's leading cash-for-junk-cars companies, is improving ... to be more competitive and help bring a little ... festive time of year. , Along with purchasing expensive ... the US also deal with large travel expenses during ...
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
Breaking Medicine News(10 mins):Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3
... September 11, 2011, one of the most critical challenges that ... victims trapped under debris a painful and tedious race ... been a losing race when relying on drills, saws, and ... and Technology Directorate (S&T) has developed a new tool to ...
... Sept. 21, 2011 Patients at Virginia G. Piper Cancer ... participate in a clinical trial to determine the safety, tolerability ... proteins associated with the most common form of lung cancer, ... and neuroblastoma. The first patient on the study ...
... News) -- Differences in the genetic makeup of prostate cells ... more likely to get prostate cancer and die from it ... a lot of socioeconomic and environmental factors that create differences ... co-author Bi-Dar Wang, assistant research professor of pharmacology and physiology ...
... Administration of the commonly used stimulant drug methylphenidate (Ritalin) was ... study conducted at Massachusetts General Hospital (MGH). The report, ... the first demonstration in mammals of what could be a ... While there are drugs to counteract many of the ...
... NY) Researchers at Albert Einstein College of ... by rheumatologists and the use of immunosuppressant drugs improve the ... could reverse long-standing clinical practice. Their study appeared in the ... At least 1.5 million Americans (more than 90 ...
... Move over, gourmet meal. Apparently cold hard cash and a ... conclusion of new research that examined how people react when ... people salivate when they desire material objects, according to the ... Research . "Merely being exposed to the concept of ...
Cached Medicine News:Health News:Racing against time 2Health News:TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer 2Health News:Genes May Explain Blacks' Bleaker Prostate Cancer Stats 2Health News:Common stimulant may speed recovery from general anesthesia 2Health News:Common stimulant may speed recovery from general anesthesia 3Health News:Continued treatment for lupus may boost survival of those patients with end-stage kidney disease 2Health News:Cash, Luxury Goods Really Do Get People Salivating: Study 2
(Date:11/26/2014)... , Nov. 26, 2014 Scott Steiger ... most of the world. As an engineer for the past 20 ... member of the military service. He,s been to six of the ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... for travelers, he has a pretty good idea of what,s required. ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... , Nov. 26, 2014 The ... at a rate of 4%, with world market ... Kalorama Information. MRI and other types of medical ... and treatment of numerous medical conditions in children ... and techniques. Kalorama,s report, Medical Imaging Markets ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... , , SEATTLE, Dec. 9 Omeros Corporation today ... to serve on the Company,s Board. Mr. Spiegelman has also been ... are very pleased to welcome Dan to our Board and look ... CEO of Omeros. "Dan brings a substantial depth and breadth of ...
... , WALTHAM, Mass., Dec. 9 Decision ... focusing on pharmaceutical and healthcare issues, finds that compared to ... are being used more often to treat newly diagnosed patients ... second-line patients received a TNF-alpha inhibitor versus one year ago ...
Cached Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3
... Infinity Triglycerides powder reagent once reconstituted ... of single liquid stability to help ... and provide quick result turnaround time. ... Triglycerides powder reagent provides a long ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The patented ... provides a long shelf life that ...
... Infinity Creatinine single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Creatinine reagent provides a long shelf ...
... Amylase powder reagent once reconstituted offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... powder reagent provides a long shelf ...
Medicine Products: